$107.53
$0.00 (0.00%)
End-of-day quote: 04/26/2024
NYSE:ABT

Abbott Laboratories Annual Report

Year Year 2023 2021 2022 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020
Rev. Revenue
$40.11B $43.08B $43.65B $19.68B $22.34B $22.48B $25.91B $29.53B $30.76B $35.17B $21.41B $19.05B $19.66B $20.25B $20.41B $20.85B $27.39B $30.58B $31.90B $34.61B
GM % Gross Margin %
55.32% 58.06% 56.31% 54.86% 53.14% 57.14% 56.29% 57.72% 57.06% 58.74% 53.42% 53.54% 53.36% 54.61% 57.22% 56.43% 58.05% 58.48% 58.53% 57.08%
OM Operating Margin
18.00% 21.40% 20.24% 21.86% 20.75% 18.98% 18.08% 20.17% 21.19% 20.02% 7.82% 8.01% 11.14% 14.26% 14.52% 15.43% 10.73% 12.55% 14.91% 16.37%
EPS Earnings Per Share
$0.00 $4.44 $5.34 $5.21 $3.65 $3.24 $2.88 $2.50 $2.20 $2.15 $1.98 $2.01 $5.07 $4.66 $4.17 $3.72 $3.32 $2.84 $2.53 $2.50 $2.27
Div. Dividends
$2.08 $1.82 $1.92 $1.04 $1.10 $1.18 $1.30 $1.44 $1.60 $1.76 $1.92 $1.67 $0.72 $0.90 $0.98 $1.05 $1.08 $1.16 $1.32 $1.53
PR % Payout Ratio %
46.85% 34.93% 35.96% 45.81% 44.00% 46.64% 45.77% 43.37% 43.01% 42.21% 41.20% 32.94% 35.82% 45.45% 45.58% 47.73% 43.20% 40.28% 40.74% 41.92%
Sha. Shares
1734.08m 1764.08m 1737.8m 1560.02m 1539.23m 1537.24m 1549.91m 1552.43m 1551.17m 1546.98m 1570.38m 1576.67m 1548.1m 1508.04m 1472.67m 1472.87m 1743.6m 1755.62m 1762.5m 1771.23m
OCF Operating Cash Flow
$7.26B $10.53B $9.58B $5.11B $5.17B $5.33B $5.18B $7.34B $7.28B $8.74B $8.97B $9.31B $3.32B $3.68B $2.97B $3.20B $5.57B $6.30B $6.14B $7.90B
FCF Free Cash Flow
$8.08B $8.65B $7.80B $3.82B $3.97B $3.99B $3.53B $6.06B $6.19B $7.72B $7.48B $7.52B $2.18B $2.60B $1.86B $2.08B $4.44B $4.91B $4.50B $5.72B
FCFS Free Cash Flow Per Share
$2.91 $4.87 $4.45 $2.45 $2.56 $2.61 $2.29 $3.92 $4.00 $4.99 $4.80 $4.77 $1.40 $1.71 $1.24 $1.41 $2.55 $2.79 $2.54 $3.23